PHARMACOKINETIC INTERACTION BETWEEN IVACAFTOR AND LUMACAFTOR IN CYSTIC FIBROSIS PATIENTS

被引：0
|
作者：
Hanafin, P. [2 ]
Rao, G. [2 ]
Schneider-Futschik, E. [1 ]
机构：
[1] Univ Melbourne, Melbourne, Vic, Australia
[2] UNC Eshelman Sch Pharm, Chapel Hill, NC USA
来源：
RESPIROLOGY | 2020年 / 25卷
基金：
英国医学研究理事会;
关键词：
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
TO 070
引用
收藏
页码：58 / 58
页数：1
相关论文
共 50 条
  • [1] Management of the interaction between lumacaftor/ivacaftor and antifungal prophylaxis in patients with cystic fibrosis
    Boglione-Kerrien, C.
    Triquet, L.
    Brinchault, G.
    Petitcollin, A.
    Tron, C.
    Lalanne, S.
    Taieb, F.
    Bellissant, E.
    Verdier, M. C.
    Lemaitre, F.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2018, 32 : 58 - 58
  • [2] Lumacaftor/Ivacaftor (Orkambi) for Cystic Fibrosis
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2016, 58 (1491): : 41 - 42
  • [3] Pathogen acquisition in patients with cystic fibrosis receiving ivacaftor or lumacaftor/ivacaftor
    Singh, Sachinkumar B.
    McLearn-Montz, Amanda J.
    Milavetz, Francesca
    Gates, Levi K.
    Fox, Christopher
    Murry, Logan T.
    Sabus, Ashley
    Porterfield, Harry S.
    Fischer, Anthony J.
    PEDIATRIC PULMONOLOGY, 2019, 54 (08) : 1200 - 1208
  • [4] Lumacaftor/Ivacaftor: A Review in Cystic Fibrosis
    Emma D. Deeks
    Drugs, 2016, 76 : 1191 - 1201
  • [5] Lumacaftor/Ivacaftor: A Review in Cystic Fibrosis
    Deeks, Emma D.
    DRUGS, 2016, 76 (12) : 1191 - 1201
  • [6] A retrospective observational study: Bidirectional pharmacokinetic interactions between ivacaftor-lumacaftor in cystic fibrosis
    Schneider, Elena
    Hanafin, Patrick
    Rao, Gauri
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [7] SAFETY AND EFFICACY OF LUMACAFTOR/IVACAFTOR IN PEDIATRIC CYSTIC FIBROSIS PATIENTS
    Wainwright, C.
    Chilvers, M.
    Hug, C.
    Marigowda, G.
    Tian, S.
    Solomon, M.
    Black, P.
    Rosenfeld, M.
    Sawicki, G.
    Hoppe, J.
    RESPIROLOGY, 2018, 23 : 141 - 141
  • [8] The safety of lumacaftor and ivacaftor for the treatment of cystic fibrosis
    Guevara, Maria Talamo
    McColley, Susanna A.
    EXPERT OPINION ON DRUG SAFETY, 2017, 16 (11) : 1305 - 1311
  • [9] Pregnancy in two patients with cystic fibrosis treated with lumacaftor/ivacaftor
    Kessler, Christina
    Duebbers, Angelika
    Grosse-Onnebrink, Joerg
    Omran, Heymut
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [10] EFFECT OF LUMACAFTOR/IVACAFTOR ON EXERCISE CAPACITY IN PATIENTS WITH CYSTIC FIBROSIS
    Tucker, M. A.
    Seigler, N.
    Rodriguez, Miguelez P.
    McKie, K. T.
    Forseen, C.
    Crandall, R. H.
    Harris, R. A.
    PEDIATRIC PULMONOLOGY, 2017, 52 : S393 - S393
12345